NOVARTIS PHARMACEUTICALS UK LIMITED – MIA 101
| Authorisation Number | UK MIA 101 |
| Category | MIA |
| Holder | NOVARTIS PHARMACEUTICALS UK LIMITED |
| Registered Address | NOVARTIS PHARMACEUTICALS UK LIMITED, 2ND FLOOR, THE WEST WORKS BUILDING, WHITE CITY PLACE, 195 WOOD LANE, LONDON, W12 7FQ, UNITED KINGDOM |
| Authorisation Date | Jun 24, 2026 |
| Legal Basis | HumanRegulation 17 of The Human Medicines Regulations 2012 (SI 2012/1916) |
| Sites | 1 |
| Manufacturing Operations | 1.1 1.1.3 1.2 1.2.2 1.3 1.3.2 1.3.2.5 |
| Importation Operations | 2.2 2.2.1 2.2.1.1 2.2.1.2 2.2.2 2.2.3 2.2.3.3 2.2.3.4 2.3 2.3.4 |
| MHRA Link | View on MHRA Website |
Sites (1)
NOVARTIS PHARMACEUTICALS UK LIMITED
BOTH
Country: UNITED KINGDOMProduct Class: Human Medicinal Products
Manufacturing
1.1 — Sterile Products
1.1.3 — Batch certification
1.2 — Non-sterile products
1.2.2 — Batch certification
1.3 — Biological medicinal products
1.3.2 — Batch certification
1.3.2.5 — Biotechnology products
Importation
2.2 — Batch certification of imported medicinal products
2.2.1 — Sterile Products
2.2.1.1 — Aseptically prepared
2.2.1.2 — Terminally sterilised
2.2.2 — Non-sterile products
2.2.3 — Biological medicinal products
2.2.3.3 — Cell therapy products
2.2.3.4 — Gene therapy products
2.3 — Other Importation Activities
2.3.4 — Products authorised under regulation 174 (supply in response to spread of pathogenic agents etc)
Content Preview
The source document is available on KeyPedia. Sign in to view.